Pradnya Joshi
Overview
Explore the profile of Pradnya Joshi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
16
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Salve V, Viswanath V, Joshi P, Dhakne M
Int J Trichology
. 2024 May;
15(4):160-162.
PMID: 38765722
Hyperthyroidism is known to cause thin, brittle hair, and premature graying. Hair shaft abnormalities in hyperthyroidism have not been described in the literature. A visible and microscopic change in the...
2.
Joshi P, Gogte P, Pai T, Gurav M, Dhanawade D, Karnik N, et al.
Int J Exp Pathol
. 2024 May;
105(3):90-99.
PMID: 38717047
Management of lung cancer today obligates a mutational analysis of the epidermal growth factor receptor (EGFR) gene particularly when Tyrosine Kinase Inhibitor (TKI) therapy is being considered as part of...
3.
Viswanath V, Joshi P, Dhakne M, Dhoot D, Mahadkar N, Barkate H
Clin Cosmet Investig Dermatol
. 2022 Dec;
15:2593-2600.
PMID: 36483748
Introduction: Lichen planus is a chronic disease with often disappointing and less than optimal treatment options. Apremilast modulates inflammatory signalling pathways which play a central role in the pathogenesis of...
4.
Shetty O, Shet T, Iyer R, Gogte P, Gurav M, Joshi P, et al.
PLoS One
. 2022 Sep;
17(9):e0274089.
PMID: 36137153
Background: Molecular tests in solid tumours for targeted therapies call for the need to ensure precision testing. To accomplish this participation in the External Quality Assessment Program (EQAS) is required....
5.
Optimizing full face subcision by means of a three-way connector and local anesthetic-filled syringe
Vishwanath T, Viswanath V, Joshi P, Patil S, Dhakne M
J Cosmet Dermatol
. 2022 May;
21(10):5293-5294.
PMID: 35500135
No abstract available.
6.
Viswanath V, Joshi P, Lawate P, Tare D, Dhoot D, Mahadkar N, et al.
Psoriasis (Auckl)
. 2022 May;
12:53-61.
PMID: 35496380
Purpose: To minimize adverse effects (AEs), apremilast is recommended to titrate at the initiation of therapy. But still, many patients experience AEs, resulting in discontinuation of therapy. As a result,...
7.
Viswanath V, Vishwanath T, Joshi P, Dabherao S, Tare D
Pediatr Dermatol
. 2021 Nov;
38(5):e41-e42.
PMID: 34750878
No abstract available.
8.
Viswanath V, Vishwanath T, Joshi P, Lawate P, Azhar S
Dermatol Ther
. 2020 Jul;
33(6):e13965.
PMID: 32621643
No abstract available.
9.
Vishwanath T, Viswanath V, Joshi P, Bagle T, Dabherao S
Dermatol Ther
. 2020 May;
33(4):e13652.
PMID: 32445221
No abstract available.
10.
Kononova A, Joshi P, Cotten S
Innov Aging
. 2019 Oct;
3(4):igz029.
PMID: 31637313
Background And Objectives: The study's objective was to explore older adults' (aged 65 or older) descriptions of behavior related to multitasking with traditional and newer media/information and communication technologies (ICTs)...